The global antibiotics market size is expected to reach USD 51.5 billion by 2028 according to a new study by Polaris Market Research. The report “Antibiotics Market Share, Size, Trends, Industry Analysis Report, By Product (Software, Device, Storage System); By Application (Drug Discovery & Development, Academic Research, Disease Diagnosis): By End-Use; By Region; Segment Forecast, 2021 - 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The collaboration between pharma companies is boosting industry growth. Pharma companies across the globe are strengthening their research efforts to develop new therapies and to reduce costly burden of drug discovery. In this direction, in July 2019, Nosopharm partnered with Evotec to develop NOSO-502, a novel antibiotic to treat Enterobacteriaceae infections. Similarly, in April 2019, Forge Therapeutics and Basilea Pharma announced research and license agreement to develop new antibiotics.
Moreover, rising public-private collaborations to fund projects related to this industry are also expected to boost market growth. For instance, in March 2019, the Global Antibiotic Research and Development Partnership (GARDP) announced a collaboration with Evotec to develop first-in-class antibiotics for the treatment of drug-resistant bacteria.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/antibiotics-market/request-for-sample
Market participants such as Abbott Laboratories, Allergan, Bayer AG, Cumberland Pharmaceuticals, Inc., Danaher, GlaxoSmithKline plc, Melinta Therapeutics, Merck & Co. Inc., Mylan, Nabriva Therapeutics plc, Novartis, Pfizer Inc., Roche , Sanofi, Teva Pharmaceutical Industries Ltd. Pharmaceutical companies across the globe are focussing on research and innovation to stay competitive and develop new anti-microbial therapies.
In line with this, in July 2020, more than dozens of pharma companies introduced AMR action fund, a collaborative effort to develop new three to four antibiotics, by the end of the decade. Group has already collected more than USD 1 billion to support clinical research for new antibiotics to address life-threatening infections. The fund would provide potential antibiotic candidates for the most challenging drug development stages and enable individual governments to make favourable reforms for potential product pipelines.
Polaris Market Research has segmented the antibiotics market report on the basis of product, application, end-use and region:
Antibiotics, Product Outlook (Revenue - USD Billion, 2016 - 2028)
Antibiotic, Application Outlook (Revenue - USD Billion, 2016 - 2028)
Antibiotic, End-Use Outlook (Revenue - USD Billion, 2016 - 2028)
Antibiotics, Regional Outlook (Revenue - USD Billion, 2016 - 2028)